Dr. Figlin on the Evolving Treatment Landscape of Renal Cell Carcinoma

Renal Cell Carcinoma: An Evolving Treatment LandscapeПодробнее

The evolving treatment landscape of renal cell carcinomaПодробнее

Dr. Figlin Discusses Future of RCC TreatmentПодробнее

Dr. Robert Figlin on the Future of Treatment for Patients with RCCПодробнее

Navigating Evolving Standards of Care in RCC: Novel Targeted and Immunotherapy OptionsПодробнее

Dr. Figlin on TKI Therapy Options in Renal Cell CarcinomaПодробнее

Dr. Robert Figlin on The Increasingly Complicated Treatment Paradigm for Renal Cell CarcinomaПодробнее

Evolving Treatment Landscape of Renal Cell CarcinomaПодробнее

The evolving first-line treatment landscape for advanced RCCПодробнее

Copy of Dr. Figlin Discusses the Future of Kidney Cancer TreatmentПодробнее

Dr. Grigg on the Future Treatment Landscape of Renal Cell CarcinomaПодробнее

Dr. Figlin on Treatment Strategies in Advanced RCCПодробнее

Changing Treatment Landscape for RCCПодробнее

Robert Figlin, MD, on treatment of returning metastatic renal cancer when priorly treated with I-OПодробнее

Robert Figlin, MD, speculates on the changing landscape of RCC treatmentПодробнее

Dr. Figlin on the Plethora of Novel Agents in RCCПодробнее

Will immunotherapy take over the treatment landscape of patients high-risk renal cell carcinoma?Подробнее

Robert Figlin, MD, discusses recent progress in the treatment of renal cell cancer (RCC)Подробнее

Robert Figlin, MD, discusses sequencing when treating metastatic RCC patientsПодробнее